PD-1/ PD-L1 bispecific antibody IBI318 combined with lenvatinib in advanced non-small cell lung cancer with acquired resistance to immune checkpoint inhibitors: a phase II trial
- Liang Zeng
- Zhaohui Ruan
- Huan Yan
- Haoyue Qin
- Zhen Zeng
- Chun Zou
- Zhe Huang
- Wenjuan Jiang
- Jiacheng Dai
- Shidong Xu
- Lianxi Song
- Yangqian Chen
- Yuda Zhang
- Fanxu Zeng
- Shiyou Wei
- Shanmei Chen
- Li Liu
- Yi Xiong
- Zhan Wang
- Jun Deng
- Xing Zhang
- Yuanze Sun
- Dan Yang
- Chunhua Zhou
- Haiyan Yang
- Yizhi Li
- Li Deng
- Qinqin Xu
- Chao Fang
- Xue Chen
- Jing Wang
- Ting Li
- Gao Zhang
- Hui Zhou
- Nong Yang
- Yongchang Zhang
2025-12-15